129 related articles for article (PubMed ID: 31639422)
1. Treating head injury using a novel vasopressin 1a receptor antagonist.
Morrison TR; Kulkarni P; Cai X; Iriah S; Aggarwal D; Lu SF; Simon NG; Madularu D; Ferris CF
Neurosci Lett; 2020 Jan; 714():134565. PubMed ID: 31639422
[TBL] [Abstract][Full Text] [Related]
2. Time-Dependent Effects of Arginine-Vasopressin V1 Receptor Inhibition on Secondary Brain Damage after Traumatic Brain Injury.
Krieg SM; Trabold R; Plesnila N
J Neurotrauma; 2017 Apr; 34(7):1329-1336. PubMed ID: 27762660
[TBL] [Abstract][Full Text] [Related]
3. Evidence of early vasogenic edema following minor head impact that can be reduced with a vasopressin V1a receptor antagonist.
Kulkarni P; Bhosle MR; Lu SF; Simon NS; Iriah S; Brownstein MJ; Ferris CF
Brain Res Bull; 2020 Dec; 165():218-227. PubMed ID: 33053434
[TBL] [Abstract][Full Text] [Related]
4. Effect of small molecule vasopressin V1a and V2 receptor antagonists on brain edema formation and secondary brain damage following traumatic brain injury in mice.
Krieg SM; Sonanini S; Plesnila N; Trabold R
J Neurotrauma; 2015 Feb; 32(4):221-7. PubMed ID: 25111427
[TBL] [Abstract][Full Text] [Related]
5. Role of vasopressin V(1a) and V2 receptors for the development of secondary brain damage after traumatic brain injury in mice.
Trabold R; Krieg S; Schöller K; Plesnila N
J Neurotrauma; 2008 Dec; 25(12):1459-65. PubMed ID: 19118456
[TBL] [Abstract][Full Text] [Related]
6. Selective vasopressin-1a receptor antagonist prevents brain edema, reduces astrocytic cell swelling and GFAP, V1aR and AQP4 expression after focal traumatic brain injury.
Marmarou CR; Liang X; Abidi NH; Parveen S; Taya K; Henderson SC; Young HF; Filippidis AS; Baumgarten CM
Brain Res; 2014 Sep; 1581():89-102. PubMed ID: 24933327
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective effect of Da Chuanxiong Formula against cognitive and motor deficits in a rat controlled cortical impact model of traumatic brain injury.
Liu ZK; Ng CF; Shiu HT; Wong HL; Chin WC; Zhang JF; Lam PK; Poon WS; Lau CB; Leung PC; Ko CH
J Ethnopharmacol; 2018 May; 217():11-22. PubMed ID: 29425850
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of vasopressin v1a receptors after traumatic brain injury.
Szmydynger-Chodobska J; Chung I; Koźniewska E; Tran B; Harrington FJ; Duncan JA; Chodobski A
J Neurotrauma; 2004 Aug; 21(8):1090-102. PubMed ID: 15319008
[TBL] [Abstract][Full Text] [Related]
9. Real-time monitoring of changes in brain extracellular sodium and potassium concentrations and intracranial pressure after selective vasopressin-1a receptor inhibition following focal traumatic brain injury in rats.
Filippidis AS; Liang X; Wang W; Parveen S; Baumgarten CM; Marmarou CR
J Neurotrauma; 2014 Jul; 31(14):1258-67. PubMed ID: 24635833
[TBL] [Abstract][Full Text] [Related]
10. Post-traumatic administration of the p53 inactivator pifithrin-α oxygen analogue reduces hippocampal neuronal loss and improves cognitive deficits after experimental traumatic brain injury.
Yang LY; Greig NH; Huang YN; Hsieh TH; Tweedie D; Yu QS; Hoffer BJ; Luo Y; Kao YC; Wang JY
Neurobiol Dis; 2016 Dec; 96():216-226. PubMed ID: 27553877
[TBL] [Abstract][Full Text] [Related]
11. Precision Effects of Glibenclamide on MRI Endophenotypes in Clinically Relevant Murine Traumatic Brain Injury.
Zusman BE; Wu Y; Kochanek PM; Vagni VE; Janesko-Feldman K; Gerzanich V; Simard JM; Karahalios K; Mihaljevic S; Raikwar S; Rani A; Rulney J; Desai SM; Catapano J; Jha RM
Crit Care Med; 2023 Feb; 51(2):e45-e59. PubMed ID: 36661464
[TBL] [Abstract][Full Text] [Related]
12. Modulation of AQP4 expression by the selective V1a receptor antagonist, SR49059, decreases trauma-induced brain edema.
Taya K; Gulsen S; Okuno K; Prieto R; Marmarou CR; Marmarou A
Acta Neurochir Suppl; 2008; 102():425-9. PubMed ID: 19388360
[TBL] [Abstract][Full Text] [Related]
13. Vasopressin V
Rauen K; Pop V; Trabold R; Badaut J; Plesnila N
J Neurotrauma; 2020 Feb; 37(4):665-674. PubMed ID: 31547764
[TBL] [Abstract][Full Text] [Related]
14. Arginine vasopressin V1a receptor-deficient mice have reduced brain edema and secondary brain damage following traumatic brain injury.
Rauen K; Trabold R; Brem C; Terpolilli NA; Plesnila N
J Neurotrauma; 2013 Aug; 30(16):1442-8. PubMed ID: 23441636
[TBL] [Abstract][Full Text] [Related]
15. Transcranial Doppler Monitoring of Dialysis Disequilibrium in an ESRD Patient with Traumatic Brain Injury.
Ghoshal S; Gomez J; Sarwal A
Neurocrit Care; 2020 Feb; 32(1):353-356. PubMed ID: 31342448
[No Abstract] [Full Text] [Related]
16. Hyaluronidase reduced edema after experimental traumatic brain injury.
Washington PM; Lee C; Dwyer MKR; Konofagou EE; Kernie SG; Morrison B
J Cereb Blood Flow Metab; 2020 Oct; 40(10):2026-2037. PubMed ID: 31648593
[TBL] [Abstract][Full Text] [Related]
17. 17β-estradiol rescues damages following traumatic brain injury from molecule to behavior in mice.
Lu H; Ma K; Jin L; Zhu H; Cao R
J Cell Physiol; 2018 Feb; 233(2):1712-1722. PubMed ID: 28681915
[TBL] [Abstract][Full Text] [Related]
18. Arginine vasopressin ameliorates spatial learning impairments in chronic cerebral hypoperfusion via V1a receptor and autophagy signaling partially.
Yang C; Zhang X; Gao J; Wang M; Yang Z
Transl Psychiatry; 2017 Jul; 7(7):e1174. PubMed ID: 28934194
[TBL] [Abstract][Full Text] [Related]
19. The selective 5-HT(1A) receptor agonist repinotan HCl attenuates histopathology and spatial learning deficits following traumatic brain injury in rats.
Kline AE; Yu J; Horváth E; Marion DW; Dixon CE
Neuroscience; 2001; 106(3):547-55. PubMed ID: 11591455
[TBL] [Abstract][Full Text] [Related]
20. Arginine-vasopressin V1a receptor inhibition improves neurologic outcomes following an intracerebral hemorrhagic brain injury.
Manaenko A; Fathali N; Khatibi NH; Lekic T; Hasegawa Y; Martin R; Tang J; Zhang JH
Neurochem Int; 2011 Mar; 58(4):542-8. PubMed ID: 21256175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
